China SXT Pharmaceuticals (SXTC) Construction in Progress (2018 - 2023)

China SXT Pharmaceuticals' Construction in Progress history runs 6 years deep, the most recent figure standing at $349390.0 for Q1 2023.

• In Q1 2023, Construction in Progress fell 3.77% year-over-year to $349390.0; the TTM figure through Mar 2023 stood at $349390.0 (down 3.77% YoY), while the FY2023 annual figure was $349390.0, down 3.77% from the prior year.
• Construction in Progress was $349390.0 for Q1 2023 at China SXT Pharmaceuticals, up from $343153.0 in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $649235.0 in Q1 2019 to a low of -$114286.0 in Q3 2020.
• Historically, Construction in Progress has averaged $312569.4 across 5 years, with a median of $349390.0 in 2023.
• The sharpest annual moves came in 2020 and 2021: Construction in Progress tumbled 163.49% in 2020, then surged 413.75% in 2021.
• A 5-year view of Construction in Progress shows it stood at $180000.0 in 2019, then plunged by 163.49% to -$114286.0 in 2020, then soared by 413.75% to $358569.0 in 2021, then decreased by 4.3% to $343153.0 in 2022, then gained by 1.82% to $349390.0 in 2023.
• The last three Construction in Progress figures came in at $349390.0 (Q1 2023), $343153.0 (Q3 2022), and $363078.0 (Q1 2022), per Business Quant data.